FDA rule change boosts access to morning-after pill

By Anne Harding

NEW YORK (Reuters Health) - Women have easier and quicker access to the morning after pill since the Food and Drug Administration ruled that the medication could be sold to adults without a prescription, a survey of pharmacies in three large US cities shows.

In 2006, the FDA approved “behind the counter” status for Plan B — meaning that people aged 18 and older can buy the emergency contraceptive over the counter, while younger people need a prescription from a doctor. The medication consists of a high dose of progesterone, and works by preventing the ovaries from releasing an egg, or delaying this release. Unlike the “abortion pill,” RU-146, it will not affect an existing pregnancy.

“The sooner you take it the more effective it is, which is why availability is so important,” Dr. Rebekah E. Gee of the University of Pennsylvania School of Medicine in Philadelphia, the lead researcher on the study, told Reuters Health. Plan B works best if it is taken within 24 hours of unprotected sex, she added.

To investigate whether the rule change had any effect on the drug’s availability, Gee and her colleagues surveyed pharmacies in Atlanta, Boston, and Philadelphia in 2005 and 2007. The first round of the survey included 1,087 pharmacies, while the second included 795.

In 2005, Gee and her team found, 23 percent of pharmacies reported being unable to dispense Plan B within 24 hours. Two years later, just 8 percent did. And 2 percent of the pharmacists surveyed in 2007 said they would refuse to dispense the drug, compared to 4 percent in 2005.

In Atlanta, where state law permits pharmacists to refuse to dispense emergency contraception if it conflicts with their moral or religious beliefs, the rate of refusal was 9 percent in 2005 and fell to 2 percent in 2007. The percentage of pharmacies that were unable to dispense the drug within 24 hours fell from 35 percent to 14 percent.

Philadelphia has no laws on the books regarding whether a pharmacist can refuse to dispense emergency contraception or requiring pharmacies to stock commonly used medications. In that city, the percentage of pharmacies reporting being unable to dispense the drug fell from 23 percent in 2005 to 10 percent in 2007, while refusal rates were 3 percent in 2005 and 4 percent in 2007.

In Boston, which has laws requiring pharmacies to stock all commonly available medications, rates of being unable to dispense Plan B or refusing to do so were low at both time points.

Plan B is extremely safe, Gee noted, with nausea being the most common side effect. She said she believes it should be available without a prescription to younger people as well. “There’s no evidence that use of Plan B leads to more intercourse or riskier behavior, even though some of its opponents have claimed that,” she added. “The data definitely show that that’s not true.”

The US has the highest rate of unplanned pregnancies in the industrial world, Gee pointed out, while 1 in 3 US women will have an abortion. Plan B does not reduce rates of unplanned pregnancy in the population at large, she added; she and her colleagues say that this is because it isn’t a replacement for routine contraception. “Only through increased access to more effective methods of contraception and by empowering women to be educated about their reproductive health will we likely see a change in unintended pregnancy rates,” they wrote.

SOURCE: American Journal of Obstetrics & Gynecology, November 2008.

Source

--------------------------------------------------------------------------------------------
Related Posts:


WASHINGTON (Reuters) - No high-quality study done to date can document that having an abortion causes psychological distress, or a “post-abortion syndrome,” and efforts to show it does occur appear to be politically motivated, U.S. researchers said on Thursday. A team at Johns Hopkins University in Baltimore reviewed 21 studies involving more than 150,000 women and

Full Post: Abortion not seen linked with depression
--------------------------------------------------------------------------------------------

By Maggie Fox, Health and Science Editor WASHINGTON (Reuters) - The U.S. government published a rule on Thursday that it defined as protecting the conscience of health care workers but which opponents call a thinly veiled attempt to deny legal abortion and contraception services to women. At least one member of Congress said she would immediately introduce

Full Post: U.S. issues controversial abortion “conscience” rule
--------------------------------------------------------------------------------------------

NEW YORK (Reuters Health) - Women’s perceptions of their bodies may sway their risk of excessive weight gain during pregnancy, a new study suggests. The study, which followed more than 1,500 women during pregnancy, found those with misperceptions about their pre-pregnancy weight were more likely to gain too many pregnancy pounds. The odds of excessive weight gain

Full Post: Body image may influence pregnancy weight gain
--------------------------------------------------------------------------------------------

By Tan Ee Lyn CHENNAI, India (Reuters) - Up to 15 percent of pregnant women in India are developing diabetes, raising the risk of their children developing the disease, said experts on Sunday, who blamed factors including malnutrition. Experts at a diabetes summit in Chennai in southern India said genetics, a sedentary lifestyle, as well as women

Full Post: Pregnant Indians risk passing diabetes to babies
--------------------------------------------------------------------------------------------

By Patricia Avila MONTEVIDEO (Reuters) - Uruguay’s Senate voted on Tuesday to decriminalize abortions during the first 12 weeks of pregnancy, a rare move for a Latin American country, but the president is expected to kill the measure. The Senate voted 17 to 13 in favor of the bill after the lower house of Congress approved it

Full Post: Uruguay Congress allows early abortions, veto looms

Site Navigation

Most Read

Search

Contact

  • kinwrite.com@gmail.com